Efficacy of an adjuvant non-face-to-face multimodal lifestyle modification program for patients with treatment-resistant major depression: A randomized controlled trial

Garcia, A. ; Yáñez, A. M. ; Bennasar-Veny, M. ; Navarro, C. ; Salva, J. ; Ibarra, O. ; Gómez-Juanes, R. ; Serrano-Ripoll, M. J. ; Oliván, B. (Universidad de Zaragoza) ; Gili, M. ; Roca, M. ; Riera-Serra, P. ; Aguilar Latorre, A. (Universidad de Zaragoza) ; Montero-Marin, J. ; García-Toro, M.

Resumen: Background: The high prevalence of depression is partly attributable to the poor response of patients to first-line antidepressants. Multimodal programs that promote a healthy lifestyle are successful in treating depression when used as a complementary therapy, but their medium- and long-term benefits have not been demonstrated for patients with treatment-resistant depression (TRD). The main aim of this study was to compare the effectiveness of a lifestyle modification program (LMP) with mindfulness-based cognitive therapy (MBCT) and a placebo-control (written suggestions for lifestyle changes) in Spanish patients with TRD. Methods: This controlled clinical trial randomized 94 patients with TRD into 3 arms. The primary outcome was the Beck Depression Inventory-II (BDI-II) score at baseline, 2, 6 and 12 months. The secondary outcomes were changes in scores that evaluated quality-of-life, adherence to the Mediterranean diet, physical activity, and social support. Results: Relative to the placebo group, the LMP and MBCT groups had significantly better quality of life (p = 0.017; p = 0.027), and the LMP group had significantly better adherence to the Mediterranean diet (p<0.001) and reduced use of antidepressants (p = 0.036). However, the three groups showed no significant differences in BDI-II score. Limitations: Only about half of the planned 180 patients were recruited, in part due to the COVID-19 pandemic. Conclusions: There was no evidence that the LMP treatment significantly reduced symptoms of depression relative to the other groups during the COVID-19 lockdown.

Idioma: Inglés

DOI: 10.1016/j.psychres.2022.114975

Año: 2023

Publicado en: PSYCHIATRY RESEARCH 319 (2023), 114975 [9 pp.]
ISSN: 0165-1781

Factor impacto JCR: 4.2 (2023)

Categ. JCR: PSYCHIATRY rank: 50 / 279 = 0.179 (2023) - Q1 - T1
Categ. JCR: PSYCHIATRY rank: 50 / 279 = 0.179 (2023) - Q1 - T1

Factor impacto CITESCORE: 17.4 - Biological Psychiatry (Q1) - Psychiatry and Mental Health (Q1)

Factor impacto SCIMAGO: 2.189 - Psychiatry and Mental Health (Q1) - Biological Psychiatry (Q1)

Financiación: info:eu-repo/grantAgreement/ES/ISCIII/CP21-00080
Financiación: info:eu-repo/grantAgreement/ES/MCINN/RTI2018-093590-B-I00

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Psicología Social (Dpto. Psicología y Sociología)
Área (Departamento): Área Psicolog.Evolut.Educac (Dpto. Psicología y Sociología)